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Several studies have been conducted in recent years to elucidate the structure, func-
tion  and signiﬁcance of AcrB, MarA, SoxS and RamA in Salmonella enterica. In this study,
the  relative quantiﬁcation of acrB, soxS, marA and ramA genes expression was  evaluated
in  14 strains of S. enterica, with or without accompanying mutations in the quinolone
resistance-determining regions of the gyrA gene, that were exposed to ciproﬂoxacin dur-
ing  the exponential growth phase. The presence of ciproﬂoxacin during the log phase of
bacterial growth activated the genes marA, soxS, ramA and acrB in all S. enterica strains ana-
lyzed  in this study. The highest expression levels for acrB were observed in strains with
gyrA  mutation, and marA showed the highest expression in the strains without muta-
tion.  Considering only the strains with ciproﬂoxacin minimum inhibitory concentration
values  < 0.125 g/mL (sensitive to ciproﬂoxacin), the most expressed gene in the strains
both  with and without mutations was acrB. In the strains with ciproﬂoxacin minimum
inhibitory  concentration values ≥ 0.125 g/mL (low susceptibility), with and without muta-
tions  in gyrA, the most expressed gene was marA. In this study, we observed that strainsresistant  to nalidixic acid may express genes associated with the efﬂux pump and the
expression  of the AcrAB-TolC pump genes seems to occur independently of mutations ingyrA.
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Introduction
The resistance of Salmonella enterica to quinolones is usu-
ally  mediated by mutations in topoisomerase genes. However,
the  presence of plasmids and active efﬂux pumps can be
determinant factors in decreased antibiotic susceptibility and
increased  resistance.1
Efﬂux pumps act in response to bacterial stress and the
expression of pumps reduces the accumulation of organic
compounds or antimicrobial agents within the cell and can
also  be caused by chromosomal mutations, resulting in mul-
tiple  antibiotic resistance (MAR).2 According to Baucheron
et  al.,3 efﬂux pumps play an important role in resistance, espe-
cially  when ﬂuoroquinolones are involved.
The AcrB efﬂux pump belongs to the resistance-
nodulation-cell division (RND) superfamily and acts in
association with two types of proteins: the outer membrane
channel (TolC) and a periplasmic ‘adaptor’ protein (AcrA).4
Regulators belonging to the AraC/Xyls family of transcrip-
tional  activators,5 i.e. marA,6 soxRS,7 rob,8 and ramA9 have
been  found to activate acrAB transcription by binding to the
marbox  sequence characterized in its promoter.10
The MarA and SoxS proteins can activate acrAB expres-
sion.  The marRAB operon is responsible for producing the
MarA  transcriptional activator protein,6 which can be syn-
thesized  in response to the presence of antibiotics and can
result  in the multi-drug resistance phenotype (MDR). In turn,
the  soxRS operon is activated in response to oxidative stress,
with  the SoxS protein subsequently acting as transcriptional
activator.11 The overexpression of soxRS also contributes to
increased  antibiotic resistance in Gram-negative bacteria.
The  product of the ramR gene regulates the gene ramA,12
which produces the protein RamA. RamA is homologous to
MarA  and SoxS.13 Bacteria overexpressing ramA may  exhibit
the  MDR  phenotype by inducing expression of acrAB and tolC.9
S. enterica strains with the tolC gene experimentally deleted
show  an increased susceptibility to antimicrobial agents.14
Similarly, strains of S. enterica showed higher susceptibility to
ciproﬂoxacin when ramA was  inactivated.15
Although several studies have been conducted in recent
years  to elucidate the structure, function and signiﬁcance of
AcrB,  MarA, SoxS and RamA,16–18 their regulation in S. enter-
ica  is not fully understood. In this study, the expression of
acrB,  soxS, marA and ramA was  evaluated in fourteen strains
of  S. enterica, with or without accompanying mutations in the
quinolone  resistance-determining regions (QRDR) of the gyrA
gene,  that were  exposed to ciproﬂoxacin during the exponen-
tial  growth phase.
Materials  and  methods
Strains
We  analyzed 14 strains of S. enterica that are resistant to
nalidixic  acid (NAL). These strains were  divided into two
groups:  seven strains without mutation in the QRDR region
of  the genes gyrA, gyrB, parC and parE and seven strains with
mutations  in the QRDR of gyrA, but with no mutations in 1 3;1  7(2):125–130
the QRDR of other genes. Among the strains with mutations
in  the gyrA QRDR, one was positive for the qnrB19 plasmid
gene.  The ciproﬂoxacin minimum inhibitory concentration
(CipMIC) of each strain was  determined using E-test gradient
strips  (AB Biodisk, Solna, Sweden). Once the CipMIC had been
determined,  each strain was cultivated in duplicate for 2 h
in  Mueller-Hinton broth (MHB) and ciproﬂoxacin was  added
to  one of the two cultures at a concentration corresponding
to half of the correspondently CipMIC of each strain.19 After
30  min  of exposure to the antibiotic at 37 ◦C, the culture was
centrifuged for subsequent RNA extraction.
RNA  isolation
RNA isolation was performed according to Chomczynski and
Sacchi20 by the guanidinium-thiocyanate–phenol–chloroform
method,  with some modiﬁcations. After centrifugation at
14,000  × g for 10 min, the supernatant was discarded, 200 L
of  lysis solution was added and the samples were  incu-
bated  for 1 h at 37 ◦C. After this time, 50 L of 1% SDS  was
added. After vortex agitation, 25 L of 2 M NaCl and 200 L
phenol:chloroform were  mixed into the material; which was
placed  on ice for 10 min. The material was  then centrifuged
at  14,000 × g for 20 min  at 4 ◦C, and the supernatant was
recovered. An equal volume of isopropanol was  added to the
supernatant;  mixture was  incubated at −70 ◦C for 2 h and then
centrifuged at 14,000 × g for 11 min  at 4 ◦C. After the super-
natant was  discarded, the pellet was  dried under air ﬂux and
then  vortexed in 750 L of 75% ethanol. A new centrifugation
was  conducted at 14,000 × g for 11 min  at 4 ◦C; the supernatant
was  discarded; the pellet was  dried for 1 h and resuspended in
30 L of nuclease-free water (InvitrogenTM). The RNA samples
were  treated with RQ1 DNase (Ambion AM 1906), following
the  manufacturer’s instructions. RNA purity and concentra-
tion  was  measured using the Nanodrop ND-1000.
Reverse  transcriptase  (RT)
RT reactions were conducted as described by Chico et al.,21
using 1 g of total RNA, 90 ng of random hexamers (QIAGEN®)
and  0.5 mM dNTPs (InvitrogenTM). Prior to cDNA synthesis,
denaturation was  performed for 5 min  at 65 ◦C. After this step,
200  U of MMLV reverse transcriptase (InvitrogenTM), 10 mM of
DTT  (InvitrogenTM), and 20 units of RNase inhibitor (RNase
OUT,  Invitrogen) were added to each reaction to a ﬁnal vol-
ume  of 20 L. The reaction conditions were 10 min  at 25 ◦C,
15  min  at 42 ◦C and 5 min  at 99 ◦C.
Relative  quantiﬁcation  of  gene  expression
After obtaining the cDNA, quantitative real-time reverse
transcriptase PCR (qRT-PCR) was  performed using the 7500
Real-Time  PCR System, SDS software version 1.4 (Applied
Biosystems). The reactions were performed in a ﬁnal vol-
ume  of 20 L, containing 300 nM of each primer, 100 nM of
each  probe (Table 1), 2 L of cDNA and 1× TaqMan® uni-
versal master mix  (Applied Biosystems). Standard curves
were  constructed to calculate the gene-speciﬁc PCR efﬁciency
from  10-fold series dilution of the mixed cDNA template for
each  primer pair. The efﬁciency of qRT-PCR reactions was
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Table 1 – TaqMan® primers and probes. Sequences of
primers and probes used for qRT-PCR (quantitative
real-time reverse transcriptase PCR) reactions, designed
with  the help of the Primer ExpressTM 2.0 software
(Applied Biosystems).
Primers and probesa Primers sequences 5′ → 3′
16s-F CGTGTTGTGAAATGTTGGGTTAA
16s-R  CCGCTGGCAACAAAGGATAA
probe  16s TCCCGCAACGAGCGCAACC
acrB-F TGAAGACCAGGGCGTATTCCT
acrB-R TTTTTGCGTGCGCTCTTG
probe  acrB ACAATGGTCCAGCTCCCCGCG
soxS-F CGGAATACACGCGAGAAGGT
soxS-R  GAGCGCCCGATTTTTGATATC
probe soxS TGCTGCGATACATAGCCCAGGTCCA
marA-F GACCCGGACGTTCAAAAACTAT
marA-R  TCGCCATGCATATTGGTGAT
probe  marA TGATGTGCCGCCACACAAATACCG
ramA-F  CCAGAAGGTGTATGATATTTGTCTCAAG
ramA-R GGTTGAACGTGCGGGTAAA
probe  ramA TTGATTCGCAGCAAACCTTTACGCG
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sion  and the presence of mutations in topoisomerase genesProbe used: 6-carboxyﬂuorescein (FAM); quencher used: 6-
carboxytetramethylrhodamine (TAMRA).
alculated using the formula E = [10(−1/S)] − 1, where E rep-
esents the calculated efﬁciency, and S is the slope of the
tandard  curve.22 To check all primers speciﬁcity, real-time
CR  was  performed on cDNA and products were analyzed
y  electrophoresis on 2% agarose gel and ethidium bromide
taining.  Negative qRT-PCR control with no templates was  per-
ormed  for each primer pair.22
tatistical  analysis
he results were analyzed using SPSS 18.0 software. The geo-
etric  means (GM) of the CipMICs were calculated using
he  following n
√
y1y2y2· · ·yn formula: where y represents the
ndividual CipMIC of each strain, and n represents the total
umber  of CipMIC values.23
esults
he presence of ciproﬂoxacin during the log phase of bacte-
ial  growth activated at least one of the four genes tested in
ll  S. enterica strains analyzed in this study. The expression
evels of the genes marA, soxS and ramA were  higher in the
trains  without a mutation in gyrA, gyrB, parA or parC than for
trains with mutations. However, the highest expression levels
or  acrB were  observed in strains with gyrA mutation (Fig. 1).
The  GM value for the four pump genes evaluated in
almonella strains without mutations was  2.70, and for strains
ith  a mutation in gyrA it was  2.13. Among the strains mutated
n  gyrA, strain 209-2 showed higher expression of the genes
nalyzed,  with a 5.99 GM.  In contrast, the strain without muta-
ion  in gyrA with the highest levels of gene expression was
38-2,  with a 15.38 GM (Table 2).After assessing the level of expression for each gene in the
trains  without mutation, marA showed the highest expres-
ion  (GM = 6.93), followed by soxS (GM = 2.72), acrB (GM = 2.38)3;1 7(2):125–130  127
and ramA (GM = 1.16). In the strains with mutations in gyrA,
the  gene marA also showed higher levels of gene expres-
sion  (GM = 3.41) but was  followed by acrB (GM = 3.25), soxS
(GM  = 1.77) and ramA (GM = 1.05).
Considering only the strains with CipMIC val-
ues < 0.125 g/mL (sensitive to ciproﬂoxacin), the most
expressed gene in the strains both with and without muta-
tions  was acrB. In the three mutated strains, the GM for this
gene  was  9.28, and in the strain without mutation the level of
expression  of acrB was  11.8 (Table 2).
In the strains with CipMIC values ≥ 0.125 g/mL (low sus-
ceptibility), with and without mutations in gyrA, the most
expressed  gene was  marA. For the four mutated strains, marA
expression  ranged from 0.98 to 11.96, and the GM was  3.36.
In  contrast, for the six strains without mutation, the marA
expression level ranged from 1.29 to 122, with a GM of 6.62.
Among  the four strains with gyrA mutations and reduced
susceptibility to ciproﬂoxacin, strain 288-2, serovar Heidel-
berg,  and strain 300-2, serovar Enteritidis, scarcely expressed
the  pump genes tested. On the other hand, S. Enteritidis strain
209-2,  despite a GM of 5.99, presented a CipMIC value four
times  lower than S. Enteritidis strain 216-2, which showed a
GM of 1.66 (Table 2).
Four of the six strains without mutations and reduced sus-
ceptibility  to ciproﬂoxacin showed signiﬁcant expression of
the  efﬂux pump genes evaluated, with GM values between 4.25
and 15.26. In contrast, strain 232-2, with no mutation in gyrA
and  the lowest level of gene expression linked to the pump
(GM  = 0.23), presented a CipMIC value of 0.5 g/mL. Strain 297-
2,  serovar Corvallis, positive for the qnrB19 plasmid gene, also
presented  no expression of any of the four genes studied that
are  linked to the pump complex (GM = 0.65).
Discussion
There are reports that AcrAB pump expression in
Escherichia coli can increase the MIC for ciproﬂoxacin and
norﬂoxacin up to ﬁve times.24 In this study, all the strains
evaluated showed expression of at least one gene related
to  efﬂux pumps in the presence of ciproﬂoxacin. However,
the  expression of these genes and their relationship with
reduced  susceptibility to ciproﬂoxacin was  highly divergent,
independent of mutations in gyrA. The S. Enteritidis strains
250-2,  229-2 and 213-2, with mutations in gyrA and expression
of  at least 3 genes linked to the pump, presented CipMIC
values of less than 0.125 g/mL.
However, other S. Enteritidis strains (209-2, 300-2 and
216-2),  with gyrA mutations and both with and without expres-
sion  of the genes studied, showed reduced susceptibility to
ciproﬂoxacin.
Baucheron  et al.3 have reported a reduction of up to 64-
fold  in CipMIC values after inhibition of the AcrAB operon in
strains  of S. Typhimurium, with or without mutations in gyrA.
Morgan-Linnell et al.25 also failed to correlate AcrAB expres-with  the MIC for ﬂuoroquinolones. The increase in the levels
of  AcrAB expression did not always increase the MICs, suggest-
ing  that isolated AcrAB expression does not generate high MIC
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Fig. 1 – Distribution of the expression levels of the marA, soxS, ramA and acrB genes studied in relation to CipMIC (g/mL)
xacinand gyrA gene mutations. WT,  wild-type strain; CIP, ciproﬂo
values. Furthermore, the expression of the efﬂux pump was
reported  as being responsible only for baseline resistance.26
In this study, strains of S. Enteritidis without QRDR muta-
tions  in the genes gyrA, gyrB, parC or parE showed reduced
Table 2 – Distribution of the mutations observed in QRDR of the
the corresponding minimal inhibitory concentration for ciproﬂo
Straina Serotype CipMIC (g/mL) Mutation 
soxS db
250-2 Enteriditis 0.0156 Ser83-Tyr 1.39 0.1
229-2 Enteriditis 0.0156 Asp87-Asn 1.88 0.1
213-2 Enteriditis 0.0156 Asp87-Asn 0.40 0.3
209-2 Enteriditis 0.1250 Ser83-Tyr 9.65 0.1
300-2 Enteriditis 0.2500 Ser83-Phe 1.99 0.6
288-2 Heidelberg 0.5000 Ser83-Tyr 2.71 0.4
216-2 Enteriditis 0.5000 Ser83-Tyr 1.00 0.1
238-2 Enteriditis 0.2500 wt 42.2 0.2
121-1 Enteriditis 0.3800 wt 4.66 0.3
135-2 Enteriditis 0.3800 wt 2.90 0.4
91-1 Enteriditis 0.1250 wt 6.96 0.9
119-2 Enteriditis 0.0470 wt 2.27 0.1
232-2 Enteriditis 0.5000 wt 0.16 0.6
297-2d Corvallis 0.5000 wt 0.79 0.3
wt, strain without mutations in gyrA, gyrB, parC and parE.
a All strains were resistant to NAL.
b Typical deviation.
c Geometric mean of the four genes.
d Strain positive for qnrB19..
susceptibility to ciproﬂoxacin. The expression of genes asso-
ciated  with the efﬂux pump seems to have inﬂuenced this
reduction.  Strains 121-1, 135-2, 91-1 and 238-2 of S. Enteritidis
showed a GM of 4.94, 4.25, 5.25 and 15.26, respectively. In this
 gyrA gene in Salmonella strains of different serovars with
xacin (CipMIC) and geometric mean (GM) data.
Level of expression in the presence of ciproﬂoxacin
marA db acrB db ramA db GMc
1 7.26 0.51 7.67 0.38 2.46 0.26 3.71
4 2.60 0.47 4.70 0.07 19.43 0.78 4.60
0 2.26 0.20 22.16 0.16 9.78 0.33 3.74
3 11.96 0.30 37.27 0.54 0.30 0.85 5.99
1 3.16 0.10 0.00 0.00 0.00 0.00 0.50
6 0.98 1.30 0.59 0.79 0.00 0.00 0.63
1 3.43 0.16 2.20 0.27 1.01 0.70 1.66
9 9.65 0.40 3.43 0.22 38.85 0.19 15.26
1 2.82 0.72 7.89 0.40 5.74 0.46 4.94
5 122 0.20 9.19 0.24 0.00 0.00 4.25
6 8.50 0.43 1.56 0.14 8.22 0.43 5.25
8 9.19 0.38 11.80 0.36 1.25 0.30 4.19
8 1.29 0.39 0.00 0.00 0.13 1.25 0.23
3 2.31 0.13 0.97 0.19 0.00 0.00 0.65
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roup, it is important to note that strain 135-2 presented marA
xpression  of 122, and strain 238-2 of S. Enteritidis increased
xpression of both the soxS and ramA genes as well as marA
Table  2).
The  expression of marA is induced by a number of sub-
tances, including quinolones.27 The marA gene is able to
ediate  drug resistance by decreasing expression of the OmpF
orin  and causing overexpression of the AcrB efﬂux pump.6,16
tudies with E. coli reported MIC  values for oﬂoxacin up to
ightfold  higher in strains with overexpression of the marA
ene,  in comparison to strains that only had mutations in
yrA.12,28,29 Kern et al.30 observed that the rate of successful
reatment of E. coli with ﬂuoroquinolones was  signiﬁcantly
ower in strains that expressed marA. In clinical isolates,
ncreased levels of AcrAB pump gene expression may  arise
ue  to changes in marA or to bactericidal protection generated
y  the regulators of this gene. The fact that the marA gene is
ssociated  with the marRAB operon activator suggests its use
marA)  as a target for studies on strategies against microbial
esistance.25
The soxS gene was  the most expressed, after marA, in the
on-mutated strains analyzed in this study. This gene is the
ranscription  activator that positively regulates the expres-
ion  of more  than 20 genes related to the increased synthesis
f  proteins associated with the AcrAB-TolC efﬂux pump.31–33
he SoxRS regulatory system protects cells against oxidative
tress  generated by various antimicrobials.32 The S. Enteritidis
train  238-2, without mutations in gyrA, showed expression
f  the soxS gene and reduced susceptibility to ciproﬂoxacin.
ehrenberg et al.34 observed an eightfold increase in the Cip-
IC  values of S. Virchow strains when soxS was  expressed but
o relationship with the presence of gyrA mutations.
The expression of efﬂux pump genes was  practically zero
or  the Heidelberg serovar strain (GM = 0.63), which showed the
ighest  CipMIC among all the strains analyzed in this study.
t  suggests that this reduction in susceptibility is due to the
ntrinsic  resistance commonly observed in this serovar.35
The Corvallis serovar presented a CipMIC of 0.5 g/mL, but
o  mutation in the QRDR region of the topoisomerase genes
hat  correlates with the low expression levels for the studied
enes  related to efﬂux pumps. However, the reduced suscep-
ibility  to ciproﬂoxacin observed may  relate to the presence
f  the qnrB19 plasmid gene. According to Li,36 the qnr gene
acilitates the selection of chromosomal mutations related to
uinolone resistance in S. enterica by signiﬁcantly increasing
he  levels at which mutants can be selected.
The 232-2 S. Enteritidis strain presented a CipMIC of
.5  g/mL and did not express any of the studied genes linked
o  the efﬂux pump. It is possible that alternative mechanisms
f  gene regulation, such as acrR, that are independent of mar-
ox-rob  were  responsible for controlling the expression of AcrB
n S. enterica.37 Mutations in genes controlling the transcrip-
ion  or expression of other genes, such as acrD, acrA or tolC15
ay  also be involved, in addition to the AcrEF efﬂux previously
escribed in S. enterica.38,39
Another possibility for the reduced susceptibility to
iproﬂoxacin observed in strain 232-2 could be mutations
n  gyrA outside the QRDR region. Capoor et al.40 have sug-
ested  an increase to the regional boundaries that include
he  QRDR of the gyrA gene because mutations associated with3;1 7(2):125–130  129
resistance to quinolones were  observed beyond the current
domain.
In  this study, we observed that strains resistant to NAL
may  express genes associated with the efﬂux pump as a
form  of primary resistance to this drug. This mechanism may
perform  a pre-selection for less sensitive strains, with the
subsequent emergence of mutated and resistant strains. One
possible mechanism to increase the life of quinolones and
ﬂuoroquinolones would be the development of inhibitors of
the  AcrAB-TolC system, which could minimize the selection
of  strains resistant to NAL. The expression of the AcrAB-TolC
pump  genes seems to occur independently of mutations in
gyrA,  because strains without mutations in the QRDR regions
of  the topoisomerase genes evaluated in this study presented
higher  expression of the genes associated with the efﬂux
pumps.  However, the results indicate the need for additional
studies  to better understand the complex interplay between
the  expression and regulation of efﬂux pump genes and other
mechanisms  of resistance to quinolones in S. enterica.
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